Acute myocarditis: Multiparametric cardiac MR imaging

Radiology

Volumn 273, Issue 2, 2014, Pages 383-392

  Luetkens, Julian A ^a   Doerner, Jonas ^a   Thomas, Daniel K ^a   Dabir, Darius ^a   Gieseke, Juergen ^a,b   Sprinkart, Alois M ^a   Fimmers, Rolf ^b   Stehning, Christian ^c   Homsi, Rami ^a   Schwab, Joerg O ^b   Schild, Hans ^a   Naehle, Claas P ^a  

^a Departments of Radiology   (Germany)

^b UNIVERSITY OF BONN   (Germany)

^c PHILIPS RESEARCH LABORATORIES   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM; BIOLOGICAL MARKER; CONTRAST MEDIUM;

ACUTE DISEASE; ADULT; ARTICLE; CARDIAC IMAGING; CLINICAL ASSESSMENT; CLINICAL FEATURE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FEMALE; HUMAN; IMAGING SYSTEM; MAJOR CLINICAL STUDY; MALE; MYOCARDITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; TISSUE CHARACTERIZATION; AGED; BLOOD; CARDIAC GATED IMAGING; CLINICAL TRIAL; COMPUTER ASSISTED DIAGNOSIS; DIAGNOSTIC USE; DIFFERENTIAL DIAGNOSIS; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; EXERCISE TEST; MIDDLE AGED; PROCEDURES;

ACUTE DISEASE; ADULT; AGED; BIOLOGICAL MARKERS; CARDIAC-GATED IMAGING TECHNIQUES; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; EXERCISE TEST; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCARDITIS; PROSPECTIVE STUDIES;

EID: 84910068870     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.14132540     Document Type: Article

References (37)

1. Baccouche H, Mahrholdt H, Meinhardt G, et al. Diagnostic synergy of non-invasive cardiovascular magnetic resonance and invasive endomyocardial biopsy in troponinpositive patients without coronary artery disease. Eur Heart J 2009;30(23):2869- 2879.
2. Feeley KM, Harris J, Suvarna SK. Necropsy diagnosis of myocarditis: A retrospective study using CD45RO immunohistochemistry. J Clin Pathol 2000;53(2):147-149.
3. Felker GM, Thompson RE, Hare JM, et al. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med 2000;342(15):1077- 1084.
4. Drory Y, Turetz Y, Hiss Y, et al. Sudden unexpected death in persons less than 40 years of age. Am J Cardiol 1991;68(13):1388- 1392.
5. Phillips M, Robinowitz M, Higgins JR, Boran KJ, Reed T, Virmani R. Sudden cardiac death in Air Force recruits. A 20-year review. JAMA 1986;256(19):2696-2699.
6. Friedrich MG, Sechtem U, Schulz-Menger J, et al. Cardiovascular magnetic resonance in myocarditis: A JACC White Paper. J Am Coll Cardiol 2009;53(17):1475-1487.
7. Friedrich MG, Strohm O, Schulz-Menger J, Marciniak H, Luft FC, Dietz R. Contrast media-enhanced magnetic resonance imaging visualizes myocardial changes in the course of viral myocarditis. Circulation 1998;97(18):1802-1809.
8. Abdel-Aty H, Boyé P, Zagrosek A, et al. Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis: comparison of different approaches. J Am Coll Cardiol 2005;45(11):1815-1822.
9. Gutberlet M, Spors B, Thoma T, et al. Suspected chronic myocarditis at cardiac MR: diagnostic accuracy and association with immunohistologically detected inflammation and viral persistence. Radiology 2008; 246(2):401-409.
10. Mahrholdt H, Wagner A, Deluigi CC, et al. Presentation, patterns of myocardial damage, and clinical course of viral myocarditis. Circulation 2006;114(15):1581-1590.
11. Yilmaz A, Mahrholdt H, Athanasiadis A, et al. Coronary vasospasm as the underlying cause for chest pain in patients with PVB19 myocarditis. Heart 2008;94(11):1456-1463.
12. Kawel N, Nacif M, Zavodni A, et al. T1 mapping of the myocardium: intra-individual assessment of the effect of field strength, cardiac cycle and variation by myocardial region. J Cardiovasc Magn Reson 2012;14:27.
13. Simonetti OP, Finn JP, White RD, Laub G, Henry DA. "Black blood" T2-weighted inversion-recovery MR imaging of the heart. Radiology 1996;199(1):49-57.
14. Kramer CM, Barkhausen J, Flamm SD, Kim RJ, Nagel E; Society for Cardiovascular Magnetic Resonance Board of Trustees Task Force on Standardized Protocols. Standardized cardiovascular magnetic resonance imaging (CMR) protocols, Society for Cardiovascular Magnetic Resonance: Board of Trustees Task Force on Standardized Protocols. J Cardiovasc Magn Reson 2008;10:35.
15. Look DC, Locker DR. Time saving in measurement of NMR and EPR relaxation times. Rev Sci Instrum 1970;41(2):250-251.
16. Messroghli DR, Radjenovic A, Kozerke S, Higgins DM, Sivananthan MU, Ridgway JP. Modified Look-Locker inversion recovery (MOLLI) for high-resolution T1 mapping of the heart. Magn Reson Med 2004;52(1):141-146.
17. Flett AS, Hayward MP, Ashworth MT, et al. Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans. Circulation 2010;122(2):138-144.
18. Heiberg E, Sjögren J, Ugander M, Carlsson M, Engblom H, Arheden H. Design and validation of Segment-freely available software for cardiovascular image analysis. BMC Med Imaging 2010;10:1.
19. Cerqueira MD, Weissman NJ, Dilsizian V, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 2002;105(4):539-542.
20. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: A nonparametric approach. Biometrics 1988;44(3):837-845.
21. Abdel-Aty H, Simonetti O, Friedrich MG. T2-weighted cardiovascular magnetic resonance imaging. J Magn Reson Imaging 2007;26(3):452-459.
22. Laissy JP, Messin B, Varenne O, et al. MRI of acute myocarditis: A comprehensive approach based on various imaging sequences. Chest 2002;122(5):1638-1648.
23. Jellis C, Martin J, Narula J, Marwick TH. Assessment of nonischemic myocardial fibrosis. J Am Coll Cardiol 2010;56(2):89-97.
24. Rieker O, Mohrs O, Oberholzer K, Kreitner KF, Thelen M. Cardiac MRI in suspected myocarditis [in German]. Rofo 2002;174(12): 1530-1536.
25. Klumpp B, Fenchel M, Hoevelborn T, et al. Assessment of myocardial viability using delayed enhancement magnetic resonance imaging at 3.0 Tesla. Invest Radiol 2006;41(9): 661-667.
26. Ferreira VM, Piechnik SK, Dall'Armellina E, et al. T(1) mapping for the diagnosis of acute myocarditis using CMR: comparison to T2-weighted and late gadolinium enhanced imaging. JACC Cardiovasc Imaging 2013; 6(10):1048-1058.
27. Williams ES, Kaplan JI, Thatcher F, Zimmerman G, Knoebel SB. Prolongation of proton spin lattice relaxation times in regionally ischemic tissue from dog hearts. J Nucl Med 1980;21(5):449-453.
28. Ferreira VM, Piechnik SK, Dall'Armellina E, et al. Non-contrast T1-mapping detects acute myocardial edema with high diagnostic accuracy: A comparison to T2-weighted cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2012;14:42.
29. Liu PP, Mason JW. Advances in the understanding of myocarditis. Circulation 2001; 104(9):1076-1082.
30. von Knobelsdorff-Brenkenhoff F, Prothmann M, Dieringer MA, et al. Myocardial T1 and T2 mapping at 3 T: reference values, influencing factors and implications. J Cardiovasc Magn Reson 2013;15(1):53.
31. Baughman KL. Diagnosis of myocarditis: death of Dallas criteria. Circulation 2006; 113(4):593-595.
32. Hauck AJ, Kearney DL, Edwards WD. Evaluation of postmortem endomyocardial biopsy specimens from 38 patients with lymphocytic myocarditis: implications for role of sampling error. Mayo Clin Proc 1989;64(10): 1235-1245.
33. Raman FS, Kawel-Boehm N, Gai N, et al. Modified look-locker inversion recovery T1 mapping indices: Assessment of accuracy and reproducibility between magnetic resonance scanners. J Cardiovasc Magn Reson 2013;15:64.
34. Piechnik SK, Ferreira VM, Dall'Armellina E, et al. Shortened Modified Look-Locker Inversion recovery (ShMOLLI) for clinical myocardial T1-mapping at 1.5 and 3 T within a 9 heartbeat breathhold. J Cardiovasc Magn Reson 2010;12:69.
35. Karamitsos TD, Piechnik SK, Banypersad SM, et al. Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis. JACC Cardiovasc Imaging 2013;6(4):488-497.
36. Dass S, Suttie JJ, Piechnik SK, et al. Myocardial tissue characterization using magnetic resonance noncontrast t1 mapping in hypertrophic and dilated cardiomyopathy. Circ Cardiovasc Imaging 2012;5(6):726-733.
37. Bull S, White SK, Piechnik SK, et al. Human non-contrast T1 values and correlation with histology in diffuse fibrosis. Heart 2013;99(13):932-937.